The convenience of flow cytometry for HLA-B*5701 screening to prevent abacavir hypersensitivity reactions

J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):361-2. doi: 10.1097/QAI.0b013e3181aa1382.
No abstract available

Publication types

  • Letter

MeSH terms

  • Dideoxynucleosides / adverse effects*
  • Dideoxynucleosides / therapeutic use
  • Drug Hypersensitivity / diagnosis*
  • Drug Hypersensitivity / genetics
  • Drug Hypersensitivity / prevention & control*
  • Flow Cytometry / economics
  • Flow Cytometry / methods*
  • Genetic Predisposition to Disease
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • HLA-B Antigens / analysis*
  • HLA-B Antigens / genetics
  • HLA-B Antigens / immunology
  • Humans
  • Mass Screening / economics
  • Mass Screening / methods
  • Pharmacogenetics
  • Reverse Transcriptase Inhibitors / adverse effects*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Sensitivity and Specificity

Substances

  • Dideoxynucleosides
  • HLA-B Antigens
  • HLA-B*57:01 antigen
  • Reverse Transcriptase Inhibitors
  • abacavir